Ntawm Jiangsu Jingye Pharmaceutical Co., Ltd., peb zoo siab los ua ib tus neeg koom tes ntseeg siab hauv ntiaj teb cov chaw muag tshuaj. Raws li cov chaw tsim khoom tshwj xeeb ntawm cov khoom xyaw tshuaj thiab cov khoom nruab nrab, peb nkag siab txog lub luag haujlwm tseem ceeb uasGlybenzcyclamide Intermediatesua si hauv kev tsim tshuaj thiab kev tsim khoom-tshwj xeeb hauv kev kho mob ntshav qab zib hom 2.
Peb tsis yog tsim cov tshuaj. Peb xa cov kev ntseeg siab, zoo, thiab kev thaj yeeb ntawm lub siab rau cov tuam txhab tshuaj thoob ntiaj teb.
Vim li cas peb cov Glybenzcyclamide Intermediates sawv tawm
Glybenzcyclamide Intermediates yog cov tshuaj tseem ceeb hauv kev sib xyaw ntawm sulfonylurea-chav tshuaj tiv thaiv kab mob ntshav qab zib, suav nrog Glibenclamide. Qhov zoo ntawm cov khoom nruab nrab no cuam tshuam ncaj qha rau kev ua tau zoo thiab kev nyab xeeb ntawm cov khoom siv tshuaj zaum kawg.
Ntawm Jiangsu Jingye Pharmaceutical, peb cov khoom lag luam nruab nrab-4-(2-aminoethyl) benzenesulfonamide-yog tsim los raws li kev tswj hwm nruj. Nws ua tau raws li cov qauv hauv qab no:
Purity ≥99%, validated los ntawm advanced analytical techniques (HPLC, GC, NMR)
Zoo heev stability thiab sib xws, txawm nyob rau hauv loj ntau lawm batch
Ua tiav kev tswj hwm kev txhawb nqa, suav nrog COA, MSDS, thiab cov ntaub ntawv txheej txheem
Saj zawg zog mov rau R & D, pilot, thiab coj mus muag-scale yuav tsum tau
Los ntawm kev xaiv peb cov Glybenzcyclamide Intermediates, peb cov neeg tau txais txiaj ntsig los ntawm kev sib xyaw ua ke zoo dua, kev ua tsis tiav tsawg dua, thiab lub hauv paus kev tswj hwm muaj zog.
Innovation yog nyob rau hauv peb DNA
Peb lub tuam txhab tau nruab nrog cov cuab yeej txiav-ntug thiab cov neeg ua haujlwm los ntawm pab pawg kws tshaj lij. Peb tsis tu ncua optimize peb cov txheej txheem los xyuas kom meej tias peb intermediates ua tau raws li cov kev hloov pauv ntawm kev lag luam kws tshuaj.
Peb tsis nres ntawm qhov kev cia siab - peb tshaj lawv. Peb lub tsev R & D tso cai rau peb muab cov kev cai synthesis thiab formulation tswv yim rau cov neeg nrhiav kev daws teeb meem. Txawm hais tias koj tab tom tsim cov qauv tsim los yog tsim cov tshuaj molecule tshiab, peb tuaj yeem txhawb koj pab neeg nrog kev ntseeg siab Glybenzcyclamide Intermediates.
Ib tus neeg muab khoom koj tuaj yeem ntseeg tau
Tau ntau xyoo, peb tau tsim kev sib raug zoo nrog cov tuam txhab tshuaj thoob plaws Tebchaws Europe, Asia, thiab Asmeskas. Peb cov koom tes thoob ntiaj teb vam khom rau peb rau:
Kev xa khoom raws sijhawm, txawm tias nyob hauv lub sijhawm nruj
Cov nqi sib tw, tsis muaj kev cuam tshuam rau qhov zoo
Kev sib txuas lus teb, nrog kev txhawb nqa tag nrho thiab kev tswj hwm
Ib qho ntawm peb cov neeg siv khoom nyob sab Europe, ib lub chaw tsim tshuaj lag luam nruab nrab, txhim kho lawv cov txiaj ntsig ntau lawm los ntawm 18% tom qab hloov mus rau peb cov Glybenzcyclamide Intermediates. Qhov no tau muab txhais ua cov nyiaj khaws tseg txhua xyoo ntawm ntau dua $ 200,000 thiab txo qis cov ntaub ntawv qhia txog kev sib txawv.
Peb ntseeg tias qhov no yog qhov kev sib koom tes tiag tiag zoo li: kev loj hlob ntawm kev ntseeg siab thiab kev ua tau zoo.
Lub luag haujlwm tsim khoom rau lub ntiaj teb kev noj qab haus huv
Raws li lub tuam txhab tshuaj, peb nkag siab peb lub luag haujlwm rau ob tus neeg mob thiab lub ntiaj teb. Peb cov chaw tsim khoom ua raws li GMP, ISO9001, thiab REACH cov qauv. Tsis tas li ntawd, peb tau koom tes nrog cov phiaj xwm ntsuab chemistry, txhawm rau txo cov pov tseg thiab kev cuam tshuam ib puag ncig ntawm txhua theem ntawm peb cov txheej txheem.
Peb cov kev coj ncaj ncees ua kom ntseeg tau tias txhua pawg ntawm Glybenzcyclamide Intermediates yog tsim muaj kev nyab xeeb, raug cai, thiab ruaj khov.
Ua haujlwm nrog peb
Peb ntawm Jiangsu Jingye Pharmaceutical Co., Ltd. yog ntau tshaj li tus neeg muag khoom ntawm Glybenzcyclamide Intermediates. Peb yog koj tus neeg koom tes hauv kev tsim cov tshuaj muaj kev nyab xeeb, zoo dua. Los ntawm siab purity mus rau cov khoom siv txhim khu kev qha thiab kev ua raws cai, peb xa cov khoom zoo uas koj xav tau - thiab cov kev pabcuam koj tsim nyog.
Mus saib peb lub tuam txhab lub vev xaib kom paub ntau ntxiv txog peb yog leej twg, lossis tshawb xyuas peb cov khoom lag luam tshwj xeeb, 4-(2-aminoethyl) benzenesulfonamide, saib seb peb tuaj yeem pab txhawb koj cov qauv tom ntej.
Cia peb tsim lub neej yav tom ntej ntawm kev siv tshuaj kho mob-ua ke.
Post lub sij hawm: May-06-2025